Key result
Intestinal permeability, measured by the lactulose/mannitol urinary excretion ratio, did not differ significantly between patients with chronic Chagas cardiomyopathy and healthy controls.
Why the study?
Intestinal dysfunction may contribute to a more severe disease presentation and worse outcome in patients with chronic Chagas cardiomyopathy and heart failure.
Is intestinal permeability increased in patients with chronic Chagas cardiomyopathy and LVEF <55% compared to healthy controls?
Observational (n=77)
Is intestinal permeability increased in patients with chronic Chagas cardiomyopathy and LVEF <55% compared to healthy controls?
Intestinal permeability, as measured by the lactulose/mannitol test, is not significantly altered in patients with chronic Chagas cardiomyopathy and LVEF <55% compared to healthy controls.
AIMS: We analysed intestinal permeability in patients with chronic Chagas cardiomyopathy (CCC) and evaluated its association with clinical manifestations, haemodynamic parameters measured by echocardiogram, and disease outcome. Intestinal permeability was compared between CCC patients and a group of healthy controls. BACKGROUND: Intestinal dysfunction may contribute to a more severe disease presentation with worse outcome in patients with CCC and heart failure. METHODS: Fifty patients with CCC and left ventricular ejection fraction (LVEF) of less than 55% were prospectively selected and followed for a mean period of 18 ± 8 months. A group of 27 healthy volunteers were also investigated. One patient was excluded from the analysis since he died before completing the intestinal permeability test. Intestinal permeability was evaluated with the sugar probe drink test. It consists in the urinary recovery of previously ingested sugar probes: mannitol, a monosaccharide, and lactulose, a disaccharide. RESULTS: Patient's mean age was 53.4 ± 10.4 years, and 31(63%) were male. Differential urinary excretion of lactulose/mannitol ratio did not differ significantly between healthy controls and CCC patients, regardless of clinical signs of venous congestion, haemodynamic parameters, and severity of presentation and outcome. CONCLUSIONS: The present study could not show a disturbance of the intestinal barrier in CCC patients with LVEF <55%, measured by lactulose/mannitol urinary excretion ratio. Further investigations are needed to verify if in patients with LVEF <40% intestinal permeability is increased.
No takes yet. Share an insight, caveat, or question.
Rodrigues et al. (2023) conducted an observational in Chronic Chagas cardiomyopathy (n=77). Chronic Chagas cardiomyopathy vs. Healthy volunteers was evaluated on Differential urinary excretion of lactulose/mannitol ratio. Intestinal permeability, measured by the lactulose/mannitol urinary excretion ratio, did not differ significantly between patients with chronic Chagas cardiomyopathy and healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: